Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Internet Explorer is no longer a supported browser.

This website may not display properly with Internet Explorer. For the best experience, please use a more recent browser such as the latest versions of Google Chrome, Microsoft Edge, and/or Mozilla Firefox. Thank you.

Your Environment. Your Health.

DNA METHYLTRANSFERASE GENE EXPRESSION IN COLON CANCER

Export to Word (http://www.niehs.nih.gov//portfolio/index.cfm/portfolio/grantdetail/grant_number/R01ES011858/format/word)
Principal Investigator: Baylin, Stephen B.
Institute Receiving Award Johns Hopkins University
Location Baltimore, MD
Grant Number R01ES011858
Funding Organization National Institute of Environmental Health Sciences
Award Funding Period 01 Apr 1991 to 29 Feb 2024
DESCRIPTION (provided by applicant): This long standing RO1 explores epigenetic abnormalities underlying the initiation and progression of colorectal cancer (CRC), the third most common cause of cancer deaths in the US (U.S. Cancer Statistics Working Group). We are now defining novel perspectives for CRC evolution concerning the presence and position of epigenetic changes, key causes for how they arise and are maintained, and a new understanding of the functional significance of the transcriptional abnormalities for the genes affected. During the last funding cycle, we have integrally linked all of the above with environmental stresses underlying the earliest steps in CRC tumorigenesis. These tie resulting epigenetic abnormalities to the highest CRC risk states, chronic inflammation and especially aging. The above epigenetic dynamics intersect with, and may be obligatory for key genetic alterations to drive the evolution of CRC. An integrating molecular paradigm for all of the above concerns our defining, during the present funding cycle, a novel potential role for recruiting components of the NURD transcriptional repression complex to chromatin as triggered by reactive oxygen species (ROS) exposure and resultant DNA damage . Experimentally, this can associate with initiation and maintenance of abnormal gene expression associated with enhancer and gene promoter DNA methylation. In this proposal, we make novel use of colon organoids to model how the above DNA damage dynamics can underlie epigenetic abnormalities, which allow addiction to key genetic driver mutations to foster colon CRC risk including that associated with aging. Finally, we utilize the molecular events in the above risk paradigm for defining novel targets for reversing abnormal epigenetic gene silencing during CRC initiation and progression. Our proposed studies are then important for derivation of new strategies for prevention, interception, and therapy for CRC. All of the work in our proposal has the potential to define strategies for CRC prevention, interception and therapy underpinned by a novel relationship of the emerging data to the age-risk for these cancers.
Science Code(s)/Area of Science(s) Primary: 10 - Epigenetics
Secondary: 01 - Basic Cellular or Molecular processes
Publications See publications associated with this Grant.
Program Officer Frederick Tyson
Back
to Top